10 ms·
> pharmaceutical companies inflate prices of new medications, then negotiate confidential deals that make it difficult to get a realistic comparison for the pur
by Scoundreller 7y ago
> pharmaceutical companies inflate prices of new medications, then negotiate confidential deals that make it difficult to get a realistic comparison for the purpose of setting prices.
In reality, this occurs because the “new” product is junk and no better than the cheaper generic it’s replacing. With these government-sanctioned rebates, the manufacturers save themselves the embarrassment of trying to explain why nobody’s insurance will pay for it (it’s expensive junk).
- cal5k 7y agoMaybe for some products that are merely isomers of existing off-patent medications, but biologics are pretty amazing - Hep C is basically curable now, for example.
- Scoundreller 7y agoA drug like that pretty much names its own price. Even Canada's system has exemptions from its usual pricing controls for drugs like that.